[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Funding OA
- To: liblicense-l@lists.yale.edu
- Subject: RE: Funding OA
- From: Richard Feinman <RFeinman@downstate.edu>
- Date: Tue, 16 Aug 2005 18:12:29 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
I should have said A key issue. I agree that THE key factor is the demand. My perception, however, is that the problem is not exactly as David describes it but rather the perception that new OA journals lack prestige. The concern seems to be how the journal looks to a review committee for their grant. My pitch to prospective authors is that prestige comes from the papers published not from the publisher and that PubMed and the internet have leveled the playing field. I even suggest puting in grant renewals that they chose to follow NIH guidelines by publishing in our OA journal with a prestigous editorial board and one eminent co-editor-in-chief. I think the NIH could help by explicitly encouraging study sections to look favorably on those who do chose OA (assuming the paper is inherently good). I feel, however, that part of prestige is presence and production values that color the picture. I think N&M has a unique niche in integrating molecular science and traditional nutrition but we might be said to compete somewhat with Cell Metabolism: a new journal but a spin-off of Cell which is well established and whose hard copy version and website have great impact. In essence, we (or BMC) are a start-up company trying to compete with General Motors (generic term). We (or BMC) can't go to a bank with the prospect of big profits later. An interesting example is: This month's Cell Metabolism has an ad "seeking two junior editors to join a multidisciplinary team in our Cambridge, MA, office....offers an attractive salary and benefits." N&M has one junior editor who is paid from external funds. Dr. Hussain and I are unpaid. How many researcher's can put in the kind of time that this takes for no money? I agree with David that demand is key but there has to be a mechanism for meeting the demand. Basically, Cell Metabolism is not a good deal. I subscribe because it is part of my job. It publishes a small number of articles, a fraction of which are of interest to any single person. It presumably involves a large flow of money from libraries to Elsevier. I think offering a product that will compete with this is easy in terms of value but will require a similar large flow of money to have presence. I think one good way to solve a problem is to describe an ideal solution. I will give as analogy an exam given by Dr. Fred Sachs of SUNY Buffalo in a course in cell biology. The exam had four questions: 1. Describe any problem in cell biology whose solution will guarantee you a Nobel Prize. 2. Describe how you would solve this problem using any real or imaginary equipment or techniques no matter how far out or futuristic. 3. Describe how you could adapt exisitng equipment or techniques so as to approximate the answer to question 2. 4. Why aren't you doing this? His report was that students were largely stuck on part 2, that is by their imagination. If they could answer question 2, they could come up with something for question 3. My last message was background for the question of whether we can come up with an ideal solution for the financial or organizational problem in OA. (I am working on the demand problem but will be glad to hear suggestions on that too). Regards, RF Richard D. Feinman Professor of Biochemistry Co-editor-in-chief, Nutrition & Metabolism Department of Biochemistry SUNY Downstate Medical Center ____ "David Goodman" <David.Goodman@liu.edu> Sent by: owner-liblicense-l@lists.yale.edu 08/13/05 09:23 AM Please respond to liblicense-l The key factor in causing a delay in OA is not funding. The key factor seems to be getting authors to insist upon it. The surface reason they do not, is that they do not find the process trivially easy. (Those who think it is easy may be right, but the authors don't.) The more fundamental reason is that many authors do not consider it important to have an audience outside their own research community, and thus consider readership and even citations from outside their associates to be irrelevant. (Most people outside their own field may think them wrong, but they disregard such outsiders.) The non-financial benefits of OA, however important, may not be sufficient to induce funders to require and pay for true 100% non-embargoed mandatory OA to the published items. (They should be thought sufficient, but that does not seem to be the case.) When advocates of OA disagree about how to fund it, or how much funding will be necessary, they are concerned about the secondary factors of managing the transition and ensuring sustainability. They all believe that a way to fund the necessary features will be found-- there are many possible models. However, in some cases cost might promote adoption. It should be possible to construct a system that will provide major cost savings--not 25%, which is merely three years price inflation. If so, funding agencies might choose to require it, rather than pay (directly or indirectly) the current level of publishing or subscription fees. Such a system might not involve organizations like the traditional publishers or the traditional libraries. That is not a factor in considring whether it might be more helpful to the potential users and the authors as well. Dr. David Goodman Associate Professor Palmer School of Library and Information Science Long Island University
- Prev by Date: RE: Funding OA
- Next by Date: Speech and Audio Processing: the newest open access journal fromHindawi
- Previous by thread: RE: Funding OA
- Next by thread: RE: Funding OA
- Index(es):